Drug-Induced Liver Injury during Antidepressant Treatment: Results of AMSP, a Drug Surveillance Program

International Journal of Neuropsychopharmacology

Volumn 19, Issue 4, 2016, Pages

  Friedrich, Michaela Elena ^a   Akimova, Elena ^a   Huf, Wolfgang ^e   Konstantinidis, Anastasios ^a   Papageorgiou, Konstantinos ^a   Winkler, Dietmar ^a   Toto, Sermin ^b   Greil, Waldemar ^c,d   Grohmann, Renate ^d   Kasper, Siegfried ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c Psychiatric Private Hospital   (Switzerland)

^d LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^e Christian Doppler Laboratory for Innovative Optical Imaging and its Translation to Medicine   (Austria)

Author keywords

Adverse drug reaction; antidepressants; drug surveillance; elevation of liver enzymes

Indexed keywords

AGOMELATINE; AMITRIPTYLINE; ANTIDEPRESSANT AGENT; CARBAMAZEPINE; CHLORPROTHIXENE; CITALOPRAM; CLOMIPRAMINE; CLOZAPINE; DOXEPIN; DULOXETINE; ESCITALOPRAM; FLUOXETINE; FLUVOXAMINE; GALANTAMINE; HALOPERIDOL; MELPERONE; MIANSERIN; MIRTAZAPINE; NORTRIPTYLINE; OLANZAPINE; PAROXETINE; PERAZINE; QUETIAPINE; REBOXETINE; SERTRALINE; TRAZODONE; TRIMIPRAMINE; UNINDEXED DRUG; VALPROIC ACID; VENLAFAXINE;

ABDOMINAL PAIN; ACUTE LIVER FAILURE; ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; AUSTRIA; CLINICAL FEATURE; DEPRESSION; DOSE RESPONSE; DRUG SURVEILLANCE PROGRAM; FATIGUE; FEMALE; GERMANY; HUMAN; HYPERTRANSAMINASEMIA; INCIDENCE; LIVER TOXICITY; LOSS OF APPETITE; MAJOR CLINICAL STUDY; MALE; MENTAL PATIENT; MULTICENTER STUDY (TOPIC); NAUSEA; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; SCHIZOPHRENIA; SIDE EFFECT; SWITZERLAND; TOXIC HEPATITIS; YOUNG ADULT; CHEMICAL AND DRUG INDUCED LIVER INJURY; CLINICAL TRIAL; COMBINATION DRUG THERAPY; DRUG EFFECTS; ENZYMOLOGY; HOSPITAL PATIENT; LIVER; MENTAL DISORDERS; MENTAL HOSPITAL; MIDDLE AGED; MULTICENTER STUDY; STATISTICS AND NUMERICAL DATA;

ADVERSE DRUG REACTION REPORTING SYSTEMS; AGED; ANTIDEPRESSIVE AGENTS; AUSTRIA; CHEMICAL AND DRUG INDUCED LIVER INJURY; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; FEMALE; GERMANY; HOSPITALS, PSYCHIATRIC; HUMANS; INCIDENCE; INPATIENTS; LIVER; MALE; MENTAL DISORDERS; MIDDLE AGED; SWITZERLAND;

EID: 84966283983     PISSN: 14611457     EISSN: 14695111     Source Type: Journal    
DOI: 10.1093/ijnp/pyv126     Document Type: Article

References (42)

1. Andrade RJ, Lucena MI, Alonso A, García-Cortes M, García-Ruiz E, Benitez R, Fernández MC, Pelaez G, Romero M, Corpas R, Durán JA, Jiménez M, Rodrigo L, Nogueras F, Martín-Vivaldi R, Navarro JM, Salmerón, J, de la Cuesta FS, Hidalgo R (2004) HLA class II genotype influences the type of liver injury in drug-induced idiosyncratic liver disease. Hepatology 39:1603-1612.
2. Aithal GP, Watkins PB, Andrade RJ, Larrey D, Molokhia M, Takikawa H, Hunt CM, Wilke RA, Avigan M, Kaplowith N, Bjornsson E, Daly AK (2011) Case definiation and phenotype standardization in drug-induced liver injury. Clin Pharmacol 89:806-815.
3. Benkert O, Hippius H, Fehr Ch, Gründer G, Heiser Ph, Hiemke Ch, Himmerich H, Lange-Asschendeldt Ch, Müller MJ, Paulzen M, Regen F, Steiger A (2010) Kompendium der Psychiatrischen Pharmakotherapie 8. Auflage, Springer Verlag.
4. Bernard S, Neville KA, Nguyenb AT, Flockhart DA (2006) Interethnic differences in genetic polymorphisms of CYP2D6 in the U.S. population: clinical implications. Oncologist 11:126-135.
5. Chalasani NP, Hayashi PH, Bonkovsky HL, Navarro VJ, Lee WM, Fontana RJ (2014) ACG clinical guideline: the diagnosis and management of idiosyncratic drug-induced liver injury. Am J Gastroenterol 109:950-966.
6. Chang CY, Schiano TD (2007) Drug hepatotoxicity. Aliment Pharmacol Ther 25:1135-1151.
7. Charlier C, Pinto E, Ansseau M, Plomteux G (2000) Relationship between clinical effects, serum drug concentration, and concurrent drug interactions in depressed patients treated with citalopram, fluoxetine, clomipramine, paroxetine or venlafaxine. Hum Psychopharmacol Clin Exp 15:453-459.
8. Chou WH, Yan FX, de Leon J, Barnhill JR, Cronin M, Pho MX, Ryder T, Liu W, Teiling C, Wedlund P (2000) Extension of a pilot study: impact from the cytochrome P450 2D6 polymorphism on outcome and costs associated with severe mental illness. J Clin Psychopharmacol 20:246-251.
9. Degner D, Grohmann R, Kropp S, Rüther E, Bender S, Engel RR, Schmidt LG (2004) Severe adverse drug reactions of antidepressants: results of the German Multicenter Drug Surveillance Program AMSP. Pharmacopsychiatry 37:39-45.
10. DeSanty KP, Amabile CM (2007) Antidepressant-induced liver injury. Ann Pharmacother 41:1201-1211.
11. Dodd S, Malhi GS, Tiller J, Schweitzer I, Hickie I, Khoo JP, Bassett DL, Lyndon B, Mitchell PB, Parker G, Fitzgerald PB, Udina M, Singh A, Moylan S, Giorlando F, Doughty C, Davey CG, Theodoros M, Berk M (2011) A consensus statement for safety monitoring guidelines of treatments for major depressive disorder. Aust N Z J Psychiatry 45:712-725.
12. Evans DA (1986) Ethnic differences in reactions to drugs and xenobiotics Acetylation. Prog Clin Biol Res. 214:209-242.
13. Gallego JA, Bonetti J, Zhang J, Kane JM, Correll CU (2012) Prevalence and correlates of antipsychotic polypharmacy: a systematic review and meta-regression of global and regional trends from the 1970s to 2009. Schizophr Res 138:18-28.
14. Gillman PK (2007) Tricyclic antidepresant pharmacology and therapeutic drug interactions updated. Br J Pharmacol 151:737-748.
15. Griese EU, Zanger UM, Brudermanns U, Gaedigk A, Mikus G, Mörike K, Stüven T, Eichelbaum M (1998) Assessment of the predictive power of genotypes for the in-vivo catalytic function of CYP2D6 in a German population. Pharmacogenetics 8:15-26.
16. Grohmann R, Engel RR, Möller HJ, Rüther E, Van der Velden JW, Stübner S (2013) Flupentixol use and adverese reactions in comparison with other common first- and second-generation antipsychotics: data from the AMSP study. Eur Arch Psychiatry Clin Neurosci 264:131-141.
17. Grohmann R, Engel RR, Rüther E, Hippius H (2004) The AMSP Drug Safety Program: methods and global results. Pharmacopsychiatry 37:S4-S11.
18. Grohmann R, Rüther E, Engel RR, Hippius H (1999) Assessment of adverse drug reactions in psychiatric inpatients with the AMSP drug safety program: methods and first results for tricyclic antidepressants and SSRI. Pharmacopsychiatry. 32:21-28.
19. Grohmann R, Engel RR, Geissler KH, Rüther E (2004) Psychotropic drug use in psychiatric inpatients: recent trends and changes over time-data from the AMSP study. Pharmacopsychiatry 37:S27-38.
20. Grohmann R, Rüther E, Sassim N, Schmidt LG (1989) Adverse effects of clozapine. Psychopharmacology 99:S101-104.
21. Hayashi PH, Fontana RJ (2014) Clinical features, diagnosis and natural history of drug induced liver injury. Semin Liver Dis 34:134-144.
22. Hui CK, Yuen MF, Wong WM, Lam SK, Lai CL (2002) Mirtazapine-induced hepatotoxicity. J Clin Gastroenterol 35:270-271.
23. Hurwitz N, Wade OL (1969) Intensive hospital monitoring of adverse reactions to drugs. Brit Med J 1(5643):531-536.
24. Ingelman-Sundberg M (2005) Genetic polymorphisms of cytochrome P450 2D6 (CYP2D6): clinical consequences, evolutionary aspects and functional diversity. Pharmacogenomics 5:6-13.
25. Kalra BS (2007) Cytochrome P450 enzyme isoforms and their therapeutic implications: an update. Indian J Med Sci 61:102-116.
26. Konstantinidis A, Papageorgiou K, Grohmann R, Horvath A, Engel R, Kasper S (2012) Increase of antipsychotic medication in depressive inpatients from 2000 to 2007: results from the AMSP International Pharmacovigilance Program. Int J Neuropsychopharmacol 15:449-457.
27. Krähenbühl S, Kaplowitz N (1996) Drug-induced hepatotoxicity: clinical presentation, pathogenesis, risk factors, diagnosis and treatment. In: Schmid R et al., eds. Acute and chronic liver diseases. Molecular biology and clinics. Dordrecht: Kluwer 147-158.
28. Letmaier M, Painold A, Holl AK, Vergin H, Engel R, Konstantinidis A, Kasper S, Grohmann R (2012) Hyponatraemia during psychopharmacological treatment: results of a drug surveillance programme. Int J Neuropsychopharmacol 15:739-748.
29. Macfarlane B, Davies S, Mannan K, Sarsam R, Pariente D, Dooley J (1997) Fatal acute fulminant liver failure due to clozapine: a case report and review of clozapine-induced hepatotoxicity. Gastroenterology 112:1707-1709.
30. Mansur AT, Pekcan Yaşar Ş, Göktay F (2008) Anticonvulsant hypersensitivity syndrome: clinical and laboratory features. International Journal of Dermatology 47:1184-1189.
31. Meyer UA (2000) Pharmacogenetics and adverse drug reactions. Lancet 356:1667-1671.
32. Miners JO, Birkett DJ (1998) Cytochrome P4502C9: an enzyme of major importance in human drug metabolism. Br J Clin Pharmacol. 45:525-538.
33. Norris W, Paredes AH, Lewis JH (2008) Drug-induced liver injury in 2007. Curr Opin Gastroenterol 24:287-297.
34. R Core Team (2014) R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. http://www.R-project.org/.
35. Raz A, Bergman R, Eilam O, Yungerman T, Hayek T (2001) A case report of olanzapine-induced hypersensitivity syndrome. Am J Med Sci 321:156-158.
36. Seidl LG,Thornton GF, Cluff LE (1965) Epidemiological studies of adverse drug reactions. Am J Public Health Nations Health 55:1170-1175.
37. Shenfield GM, Gross AS (1999) The cytochrome P450 system and adverse drug reactions. Adverse Drug React Bull 194:739-742.
38. Transon C, Leeman R, Dayer P (1996) In vitro comparative inhibition profiles of major drug metabolising cytochrome P450 isozymes (CYP2C9, CYP2D6, CYP3A4) by HMG-CoA reductase inhibitors. Eur J Clin Pharmacol 50:209-215.
39. Voican CS, Corruble E, Naveau S, Perlemuter G (2014) Antidepressant-induced liver injury: a review for clinicans. Am J Psychiatry 171:404-415.
40. Wilkinson GR (2004) Genetic variability in cytochrome P450 3A5 and in vivo cytochrome P450 3A activity: some answers but still questions. Clin Pharmacol and Ther 76:99-103.
41. Yatham LN, Kusumakar V, Calabrese JR (2002) Third generation anticonvulsants in bipolar disorder: a review of efficacy and summary of clinical recommendations. J Clin Psychiatry 63:275-283.
42. Zimmerman HJ (1999) Hepatotoxicity: the adverse effects of drugs and other chemicals on the liver. 2nd ed. Philadelphia: Lippincott Williams & Wilkins, Philadelphia.